Armon Sharei
Vermogen: - $ op 30-06-2026
Vermogen: - $ op 30-06-2026
Armon R.
Sharei was the founder of SQZ Biotechnologies Co. (2013), holding the title of President, Chief Executive Officer & Director.
Dr. Sharei is the founder of Portal Biotechnologies Inc. (2023), holding the title of President, CEO, Secretary, Treasurer & Director.
Dr. Sharei is currently the Chief Executive Officer at Sqz Biotechnologies, Inc. Dr. Sharei is currently an Independent Director at Genenta Science SpA, starting in 2024.
Dr. Sharei's education includes an undergraduate degree from Stanford University and a doctorate from the Massachusetts Institute of Technology.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GENENTA SCIENCE SPA -.--% | 30-03-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| GENENTA SCIENCE S.P.A. | Directeur/Bestuurslid | 02-05-2024 |
Sqz Biotechnologies, Inc. | Algemeen Directeur | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| SQZ BIOTECHNOLOGIES COMPANY | Algemeen Directeur | 30-11-2022 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
SQZ Biotechnologies Co.
SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Genenta Science SpA
Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors | Health Technology |
Sqz Biotechnologies, Inc. |
Kies jouw editie
Alle financiële informatie op nationaal niveau